Share Price and Basic Stock Data
Last Updated: October 29, 2025, 5:12 am
| PEG Ratio | 11.33 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Godrej Agrovet Ltd operates primarily in the animal and shrimp feed industry, with a current market capitalization of ₹12,703 Cr. The company reported sales of ₹9,374 Cr for the fiscal year ending March 2023, compared to ₹8,306 Cr in March 2022, indicating a growth trajectory. The revenue for the trailing twelve months (TTM) stood at ₹9,646 Cr, reflecting a continued upward trend. Quarterly sales data shows fluctuations, with the highest quarterly sales recorded at ₹2,571 Cr in September 2023, while the lowest was ₹2,095 Cr in March 2023. This revenue pattern highlights a seasonal aspect, consistent with industry trends where feed demand can vary based on livestock cycles and market conditions. Overall, Godrej Agrovet has demonstrated resilience in maintaining revenue growth, even amidst fluctuating quarterly performances, aligning with the broader growth seen in the Indian animal feed market.
Profitability and Efficiency Metrics
Godrej Agrovet reported a net profit of ₹421 Cr for the fiscal year 2025, reflecting a profit margin of 3.72%, which is higher than the previous year’s margin of 3.21%. The operating profit margin (OPM) stood at 9.16% for the fiscal year 2025, showcasing improved operational efficiency compared to 7.76% in the previous year. The company’s return on equity (ROE) was recorded at 17.7%, indicating effective management of shareholder investments. Efficiency metrics reveal a cash conversion cycle (CCC) of 42 days, demonstrating effective management of working capital. The interest coverage ratio (ICR) stood at 6.45x, indicating that earnings are sufficient to cover interest expenses, which is a positive sign of financial health. Despite these strengths, the company faces pressures from rising operational costs, as evidenced by fluctuating expenses, which could impact future profitability.
Balance Sheet Strength and Financial Ratios
Godrej Agrovet’s balance sheet reflects a robust financial position with total borrowings of ₹1,396 Cr against reserves of ₹2,189 Cr as of March 2025. The debt-to-equity ratio stood at 0.53x, indicating a balanced approach to leveraging, which is favorable compared to industry standards. The company’s book value per share was ₹123.83, suggesting a solid equity base for shareholders. Additionally, the return on capital employed (ROCE) was reported at 19.12%, showcasing efficient use of capital. However, the current ratio of 0.99x indicates a tight liquidity position, suggesting that the company may need to improve its short-term financial flexibility. The inventory turnover ratio of 6.75x signals effective inventory management, which is essential in the competitive animal feed industry.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Godrej Agrovet shows a stable commitment from promoters, who hold 67.54% of the company as of March 2025. This level of promoter holding reflects strong confidence in the company’s long-term prospects. Foreign institutional investors (FIIs) have a stake of 7.27%, while domestic institutional investors (DIIs) hold 4.97%. The public shareholding has increased to 20.22%, indicating growing retail investor interest. The number of shareholders has also risen to 1,18,739, suggesting an expanding investor base. The gradual decline in promoter holding from 74.07% in September 2022 to the current level may indicate a strategic dilution to facilitate broader market participation, enhancing liquidity. While this is generally positive, it may also raise concerns about control over decision-making processes.
Outlook, Risks, and Final Insight
Looking ahead, Godrej Agrovet is poised for continued growth, driven by increasing demand for animal and shrimp feed in India. However, the company faces several risks, including rising raw material costs and potential regulatory changes impacting the agriculture sector. The volatility in feed prices could pressure margins if not managed effectively. Additionally, competition from domestic and international players may challenge market share. Strategic initiatives focusing on product innovation and operational efficiency will be crucial for maintaining profitability. While the company is well-positioned to leverage growth opportunities in the sector, investors should remain cautious of these underlying risks that could affect performance in the near term. Overall, Godrej Agrovet’s strong fundamentals and market presence provide a solid foundation, but agile management will be essential to navigate the challenges ahead.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Godrej Agrovet Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Narmada Agrobase Ltd | 90.6 Cr. | 23.9 | 28.4/14.6 | 22.2 | 14.7 | 0.00 % | 13.0 % | 11.2 % | 10.0 |
| Godrej Agrovet Ltd | 12,703 Cr. | 660 | 876/645 | 27.9 | 124 | 1.67 % | 16.6 % | 17.7 % | 10.0 |
| Avanti Feeds Ltd | 9,836 Cr. | 722 | 965/563 | 17.0 | 206 | 1.25 % | 24.0 % | 19.5 % | 1.00 |
| Ajooni Biotech Ltd | 89.2 Cr. | 5.18 | 8.55/5.01 | 24.3 | 5.11 | 0.00 % | 6.91 % | 5.15 % | 2.00 |
| Industry Average | 11,269.50 Cr | 352.77 | 22.85 | 87.45 | 0.73% | 15.13% | 13.39% | 5.75 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,510 | 2,445 | 2,324 | 2,095 | 2,510 | 2,571 | 2,345 | 2,134 | 2,351 | 2,449 | 2,450 | 2,134 | 2,614 |
| Expenses | 2,348 | 2,295 | 2,187 | 2,020 | 2,317 | 2,369 | 2,186 | 1,986 | 2,125 | 2,225 | 2,230 | 1,987 | 2,345 |
| Operating Profit | 162 | 150 | 136 | 75 | 193 | 201 | 159 | 148 | 226 | 223 | 220 | 147 | 270 |
| OPM % | 6% | 6% | 6% | 4% | 8% | 8% | 7% | 7% | 10% | 9% | 9% | 7% | 10% |
| Other Income | 20 | 13 | 84 | 23 | 32 | 20 | 21 | 20 | 25 | 25 | 22 | 25 | 24 |
| Interest | 22 | 26 | 25 | 27 | 29 | 28 | 25 | 25 | 30 | 40 | 34 | 29 | 35 |
| Depreciation | 45 | 46 | 47 | 48 | 53 | 53 | 53 | 56 | 55 | 58 | 57 | 56 | 58 |
| Profit before tax | 116 | 92 | 148 | 23 | 142 | 141 | 102 | 87 | 166 | 150 | 151 | 87 | 200 |
| Tax % | 24% | 24% | 23% | -4% | 25% | 26% | 19% | 25% | 21% | 36% | 27% | 24% | 26% |
| Net Profit | 88 | 70 | 115 | 23 | 107 | 104 | 83 | 65 | 132 | 96 | 110 | 66 | 149 |
| EPS in Rs | 4.30 | 3.73 | 6.06 | 1.61 | 5.48 | 5.48 | 4.78 | 2.97 | 7.03 | 5.84 | 5.80 | 3.68 | 8.35 |
Last Updated: August 20, 2025, 10:15 am
Below is a detailed analysis of the quarterly data for Godrej Agrovet Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 2,614.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,134.00 Cr. (Mar 2025) to 2,614.00 Cr., marking an increase of 480.00 Cr..
- For Expenses, as of Jun 2025, the value is 2,345.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,987.00 Cr. (Mar 2025) to 2,345.00 Cr., marking an increase of 358.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 270.00 Cr.. The value appears strong and on an upward trend. It has increased from 147.00 Cr. (Mar 2025) to 270.00 Cr., marking an increase of 123.00 Cr..
- For OPM %, as of Jun 2025, the value is 10.00%. The value appears strong and on an upward trend. It has increased from 7.00% (Mar 2025) to 10.00%, marking an increase of 3.00%.
- For Other Income, as of Jun 2025, the value is 24.00 Cr.. The value appears to be declining and may need further review. It has decreased from 25.00 Cr. (Mar 2025) to 24.00 Cr., marking a decrease of 1.00 Cr..
- For Interest, as of Jun 2025, the value is 35.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 29.00 Cr. (Mar 2025) to 35.00 Cr., marking an increase of 6.00 Cr..
- For Depreciation, as of Jun 2025, the value is 58.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 56.00 Cr. (Mar 2025) to 58.00 Cr., marking an increase of 2.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 200.00 Cr.. The value appears strong and on an upward trend. It has increased from 87.00 Cr. (Mar 2025) to 200.00 Cr., marking an increase of 113.00 Cr..
- For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 24.00% (Mar 2025) to 26.00%, marking an increase of 2.00%.
- For Net Profit, as of Jun 2025, the value is 149.00 Cr.. The value appears strong and on an upward trend. It has increased from 66.00 Cr. (Mar 2025) to 149.00 Cr., marking an increase of 83.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 8.35. The value appears strong and on an upward trend. It has increased from 3.68 (Mar 2025) to 8.35, marking an increase of 4.67.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 5:17 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,102 | 3,312 | 3,750 | 4,911 | 5,186 | 5,918 | 6,964 | 6,267 | 8,306 | 9,374 | 9,561 | 9,383 | 9,646 |
| Expenses | 2,863 | 3,043 | 3,579 | 4,471 | 4,741 | 5,462 | 6,475 | 5,703 | 7,637 | 8,851 | 8,856 | 8,562 | 8,787 |
| Operating Profit | 240 | 269 | 171 | 440 | 445 | 456 | 489 | 564 | 669 | 523 | 704 | 821 | 860 |
| OPM % | 8% | 8% | 5% | 9% | 9% | 8% | 7% | 9% | 8% | 6% | 7% | 9% | 9% |
| Other Income | 36 | 104 | 315 | 95 | 58 | 154 | 49 | 90 | 109 | 139 | 90 | 93 | 96 |
| Interest | 40 | 65 | 98 | 86 | 45 | 34 | 42 | 46 | 63 | 99 | 108 | 133 | 139 |
| Depreciation | 28 | 37 | 52 | 75 | 86 | 98 | 148 | 154 | 173 | 185 | 214 | 226 | 229 |
| Profit before tax | 207 | 271 | 336 | 375 | 372 | 477 | 349 | 453 | 542 | 378 | 473 | 554 | 588 |
| Tax % | 24% | 22% | 22% | 27% | 32% | 27% | 14% | 23% | 23% | 22% | 24% | 27% | |
| Net Profit | 157 | 210 | 261 | 273 | 251 | 349 | 301 | 348 | 419 | 295 | 359 | 403 | 421 |
| EPS in Rs | 118.36 | 22.69 | 28.19 | 13.44 | 11.94 | 17.13 | 15.94 | 16.33 | 20.96 | 15.71 | 18.71 | 22.35 | 23.67 |
| Dividend Payout % | 23% | 114% | 16% | 33% | 38% | 26% | 34% | 49% | 45% | 60% | 53% | 49% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 33.76% | 24.29% | 4.60% | -8.06% | 39.04% | -13.75% | 15.61% | 20.40% | -29.59% | 21.69% | 12.26% |
| Change in YoY Net Profit Growth (%) | 0.00% | -9.47% | -19.69% | -12.66% | 47.10% | -52.80% | 29.37% | 4.79% | -50.00% | 51.29% | -9.44% |
Godrej Agrovet Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 6% |
| 3 Years: | 4% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 7% |
| 3 Years: | 1% |
| TTM: | 17% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 8% |
| 3 Years: | 12% |
| 1 Year: | -8% |
| Return on Equity | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 16% |
| 3 Years: | 15% |
| Last Year: | 18% |
Last Updated: September 5, 2025, 5:00 am
Balance Sheet
Last Updated: October 10, 2025, 2:05 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 13 | 93 | 93 | 185 | 192 | 192 | 192 | 192 | 192 | 192 | 192 | 192 |
| Reserves | 505 | 548 | 690 | 824 | 1,219 | 1,457 | 1,646 | 1,859 | 2,076 | 2,145 | 2,324 | 2,189 |
| Borrowings | 620 | 685 | 1,372 | 664 | 410 | 398 | 651 | 1,007 | 1,599 | 1,433 | 1,416 | 1,396 |
| Other Liabilities | 435 | 417 | 957 | 1,535 | 1,714 | 2,183 | 2,183 | 1,721 | 1,689 | 1,673 | 1,734 | 1,729 |
| Total Liabilities | 1,573 | 1,742 | 3,111 | 3,208 | 3,535 | 4,230 | 4,672 | 4,779 | 5,556 | 5,444 | 5,667 | 5,505 |
| Fixed Assets | 594 | 693 | 1,507 | 1,473 | 1,492 | 2,051 | 2,178 | 2,298 | 2,407 | 2,568 | 2,806 | 2,912 |
| CWIP | 149 | 138 | 64 | 50 | 190 | 94 | 153 | 141 | 90 | 204 | 192 | 64 |
| Investments | 0 | 37 | 59 | 175 | 195 | 117 | 129 | 124 | 160 | 158 | 177 | 139 |
| Other Assets | 830 | 873 | 1,481 | 1,509 | 1,657 | 1,969 | 2,211 | 2,216 | 2,900 | 2,513 | 2,492 | 2,391 |
| Total Assets | 1,573 | 1,742 | 3,111 | 3,208 | 3,535 | 4,230 | 4,672 | 4,779 | 5,556 | 5,444 | 5,667 | 5,505 |
Below is a detailed analysis of the balance sheet data for Godrej Agrovet Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 192.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 192.00 Cr..
- For Reserves, as of Mar 2025, the value is 2,189.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,324.00 Cr. (Mar 2024) to 2,189.00 Cr., marking a decrease of 135.00 Cr..
- For Borrowings, as of Mar 2025, the value is 1,396.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 1,416.00 Cr. (Mar 2024) to 1,396.00 Cr., marking a decrease of 20.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 1,729.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,734.00 Cr. (Mar 2024) to 1,729.00 Cr., marking a decrease of 5.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 5,505.00 Cr.. The value appears to be improving (decreasing). It has decreased from 5,667.00 Cr. (Mar 2024) to 5,505.00 Cr., marking a decrease of 162.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 2,912.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,806.00 Cr. (Mar 2024) to 2,912.00 Cr., marking an increase of 106.00 Cr..
- For CWIP, as of Mar 2025, the value is 64.00 Cr.. The value appears to be declining and may need further review. It has decreased from 192.00 Cr. (Mar 2024) to 64.00 Cr., marking a decrease of 128.00 Cr..
- For Investments, as of Mar 2025, the value is 139.00 Cr.. The value appears to be declining and may need further review. It has decreased from 177.00 Cr. (Mar 2024) to 139.00 Cr., marking a decrease of 38.00 Cr..
- For Other Assets, as of Mar 2025, the value is 2,391.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,492.00 Cr. (Mar 2024) to 2,391.00 Cr., marking a decrease of 101.00 Cr..
- For Total Assets, as of Mar 2025, the value is 5,505.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5,667.00 Cr. (Mar 2024) to 5,505.00 Cr., marking a decrease of 162.00 Cr..
Notably, the Reserves (2,189.00 Cr.) exceed the Borrowings (1,396.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -380.00 | -416.00 | 170.00 | -224.00 | 35.00 | 58.00 | -162.00 | 563.00 | 668.00 | 522.00 | 703.00 | 820.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 27 | 30 | 44 | 39 | 44 | 45 | 45 | 48 | 42 | 22 | 20 | 22 |
| Inventory Days | 47 | 54 | 83 | 71 | 70 | 72 | 60 | 78 | 83 | 66 | 70 | 66 |
| Days Payable | 33 | 30 | 42 | 81 | 82 | 99 | 87 | 62 | 40 | 35 | 32 | 47 |
| Cash Conversion Cycle | 40 | 54 | 85 | 29 | 31 | 18 | 17 | 64 | 84 | 54 | 58 | 42 |
| Working Capital Days | 33 | 49 | -51 | -26 | -8 | -3 | -7 | 7 | 6 | -4 | 1 | -2 |
| ROCE % | 24% | 24% | 17% | 19% | 20% | 18% | 15% | 16% | 16% | 10% | 14% | 17% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Nippon India Small Cap Fund | 2,240,862 | 0.32 | 190.81 | 2,240,862 | 2025-04-22 17:25:34 | 0% |
| Motilal Oswal Small Cap Fund | 429,229 | 1.71 | 36.55 | 429,229 | 2025-04-22 15:56:57 | 0% |
| Motilal Oswal Nifty Microcap 250 Index Fund | 60,489 | 0.38 | 5.15 | 60,489 | 2025-04-22 15:56:57 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 22.35 | 18.71 | 15.71 | 20.96 | 16.34 |
| Diluted EPS (Rs.) | 22.34 | 18.71 | 15.71 | 20.95 | 16.33 |
| Cash EPS (Rs.) | 29.95 | 27.14 | 23.36 | 28.23 | 23.50 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 123.83 | 151.97 | 142.78 | 139.96 | 128.15 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 123.83 | 151.97 | 142.78 | 139.96 | 128.15 |
| Revenue From Operations / Share (Rs.) | 488.00 | 497.40 | 487.81 | 432.36 | 326.27 |
| PBDIT / Share (Rs.) | 44.71 | 38.64 | 32.80 | 38.78 | 31.41 |
| PBIT / Share (Rs.) | 32.95 | 27.49 | 23.15 | 29.76 | 23.39 |
| PBT / Share (Rs.) | 26.02 | 21.88 | 17.99 | 25.58 | 20.97 |
| Net Profit / Share (Rs.) | 18.19 | 15.99 | 13.71 | 19.20 | 15.48 |
| NP After MI And SOA / Share (Rs.) | 22.35 | 18.71 | 15.71 | 20.96 | 16.33 |
| PBDIT Margin (%) | 9.16 | 7.76 | 6.72 | 8.97 | 9.62 |
| PBIT Margin (%) | 6.75 | 5.52 | 4.74 | 6.88 | 7.17 |
| PBT Margin (%) | 5.33 | 4.39 | 3.68 | 5.91 | 6.42 |
| Net Profit Margin (%) | 3.72 | 3.21 | 2.80 | 4.44 | 4.74 |
| NP After MI And SOA Margin (%) | 4.57 | 3.76 | 3.22 | 4.84 | 5.00 |
| Return on Networth / Equity (%) | 18.04 | 14.29 | 12.91 | 17.74 | 15.29 |
| Return on Capital Employeed (%) | 19.12 | 15.05 | 14.31 | 19.39 | 15.89 |
| Return On Assets (%) | 7.79 | 6.30 | 5.50 | 7.20 | 6.53 |
| Long Term Debt / Equity (X) | 0.19 | 0.11 | 0.02 | 0.02 | 0.07 |
| Total Debt / Equity (X) | 0.53 | 0.51 | 0.56 | 0.69 | 0.45 |
| Asset Turnover Ratio (%) | 1.67 | 1.71 | 1.69 | 1.60 | 1.11 |
| Current Ratio (X) | 0.99 | 1.04 | 0.96 | 1.06 | 1.08 |
| Quick Ratio (X) | 0.39 | 0.37 | 0.36 | 0.48 | 0.55 |
| Inventory Turnover Ratio (X) | 6.75 | 4.90 | 4.91 | 4.87 | 3.88 |
| Dividend Payout Ratio (NP) (%) | 44.74 | 50.76 | 60.46 | 38.17 | 33.67 |
| Dividend Payout Ratio (CP) (%) | 29.31 | 31.81 | 37.45 | 26.68 | 22.58 |
| Earning Retention Ratio (%) | 55.26 | 49.24 | 39.54 | 61.83 | 66.33 |
| Cash Earning Retention Ratio (%) | 70.69 | 68.19 | 62.55 | 73.32 | 77.42 |
| Interest Coverage Ratio (X) | 6.45 | 6.89 | 6.36 | 11.81 | 12.98 |
| Interest Coverage Ratio (Post Tax) (X) | 3.62 | 3.85 | 3.66 | 7.12 | 7.40 |
| Enterprise Value (Cr.) | 15963.39 | 11014.00 | 9629.43 | 10447.66 | 11375.23 |
| EV / Net Operating Revenue (X) | 1.70 | 1.15 | 1.03 | 1.26 | 1.82 |
| EV / EBITDA (X) | 18.57 | 14.83 | 15.28 | 14.02 | 18.85 |
| MarketCap / Net Operating Revenue (X) | 1.55 | 0.97 | 0.84 | 1.02 | 1.61 |
| Retention Ratios (%) | 55.25 | 49.23 | 39.53 | 61.82 | 66.32 |
| Price / BV (X) | 6.09 | 3.72 | 3.39 | 3.75 | 4.91 |
| Price / Net Operating Revenue (X) | 1.55 | 0.97 | 0.84 | 1.02 | 1.61 |
| EarningsYield | 0.02 | 0.03 | 0.03 | 0.04 | 0.03 |
After reviewing the key financial ratios for Godrej Agrovet Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 22.35. This value is within the healthy range. It has increased from 18.71 (Mar 24) to 22.35, marking an increase of 3.64.
- For Diluted EPS (Rs.), as of Mar 25, the value is 22.34. This value is within the healthy range. It has increased from 18.71 (Mar 24) to 22.34, marking an increase of 3.63.
- For Cash EPS (Rs.), as of Mar 25, the value is 29.95. This value is within the healthy range. It has increased from 27.14 (Mar 24) to 29.95, marking an increase of 2.81.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 123.83. It has decreased from 151.97 (Mar 24) to 123.83, marking a decrease of 28.14.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 123.83. It has decreased from 151.97 (Mar 24) to 123.83, marking a decrease of 28.14.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 488.00. It has decreased from 497.40 (Mar 24) to 488.00, marking a decrease of 9.40.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 44.71. This value is within the healthy range. It has increased from 38.64 (Mar 24) to 44.71, marking an increase of 6.07.
- For PBIT / Share (Rs.), as of Mar 25, the value is 32.95. This value is within the healthy range. It has increased from 27.49 (Mar 24) to 32.95, marking an increase of 5.46.
- For PBT / Share (Rs.), as of Mar 25, the value is 26.02. This value is within the healthy range. It has increased from 21.88 (Mar 24) to 26.02, marking an increase of 4.14.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 18.19. This value is within the healthy range. It has increased from 15.99 (Mar 24) to 18.19, marking an increase of 2.20.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 22.35. This value is within the healthy range. It has increased from 18.71 (Mar 24) to 22.35, marking an increase of 3.64.
- For PBDIT Margin (%), as of Mar 25, the value is 9.16. This value is below the healthy minimum of 10. It has increased from 7.76 (Mar 24) to 9.16, marking an increase of 1.40.
- For PBIT Margin (%), as of Mar 25, the value is 6.75. This value is below the healthy minimum of 10. It has increased from 5.52 (Mar 24) to 6.75, marking an increase of 1.23.
- For PBT Margin (%), as of Mar 25, the value is 5.33. This value is below the healthy minimum of 10. It has increased from 4.39 (Mar 24) to 5.33, marking an increase of 0.94.
- For Net Profit Margin (%), as of Mar 25, the value is 3.72. This value is below the healthy minimum of 5. It has increased from 3.21 (Mar 24) to 3.72, marking an increase of 0.51.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.57. This value is below the healthy minimum of 8. It has increased from 3.76 (Mar 24) to 4.57, marking an increase of 0.81.
- For Return on Networth / Equity (%), as of Mar 25, the value is 18.04. This value is within the healthy range. It has increased from 14.29 (Mar 24) to 18.04, marking an increase of 3.75.
- For Return on Capital Employeed (%), as of Mar 25, the value is 19.12. This value is within the healthy range. It has increased from 15.05 (Mar 24) to 19.12, marking an increase of 4.07.
- For Return On Assets (%), as of Mar 25, the value is 7.79. This value is within the healthy range. It has increased from 6.30 (Mar 24) to 7.79, marking an increase of 1.49.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.19. This value is below the healthy minimum of 0.2. It has increased from 0.11 (Mar 24) to 0.19, marking an increase of 0.08.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.53. This value is within the healthy range. It has increased from 0.51 (Mar 24) to 0.53, marking an increase of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.67. It has decreased from 1.71 (Mar 24) to 1.67, marking a decrease of 0.04.
- For Current Ratio (X), as of Mar 25, the value is 0.99. This value is below the healthy minimum of 1.5. It has decreased from 1.04 (Mar 24) to 0.99, marking a decrease of 0.05.
- For Quick Ratio (X), as of Mar 25, the value is 0.39. This value is below the healthy minimum of 1. It has increased from 0.37 (Mar 24) to 0.39, marking an increase of 0.02.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.75. This value is within the healthy range. It has increased from 4.90 (Mar 24) to 6.75, marking an increase of 1.85.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 44.74. This value is within the healthy range. It has decreased from 50.76 (Mar 24) to 44.74, marking a decrease of 6.02.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 29.31. This value is within the healthy range. It has decreased from 31.81 (Mar 24) to 29.31, marking a decrease of 2.50.
- For Earning Retention Ratio (%), as of Mar 25, the value is 55.26. This value is within the healthy range. It has increased from 49.24 (Mar 24) to 55.26, marking an increase of 6.02.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 70.69. This value exceeds the healthy maximum of 70. It has increased from 68.19 (Mar 24) to 70.69, marking an increase of 2.50.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 6.45. This value is within the healthy range. It has decreased from 6.89 (Mar 24) to 6.45, marking a decrease of 0.44.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.62. This value is within the healthy range. It has decreased from 3.85 (Mar 24) to 3.62, marking a decrease of 0.23.
- For Enterprise Value (Cr.), as of Mar 25, the value is 15,963.39. It has increased from 11,014.00 (Mar 24) to 15,963.39, marking an increase of 4,949.39.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.70. This value is within the healthy range. It has increased from 1.15 (Mar 24) to 1.70, marking an increase of 0.55.
- For EV / EBITDA (X), as of Mar 25, the value is 18.57. This value exceeds the healthy maximum of 15. It has increased from 14.83 (Mar 24) to 18.57, marking an increase of 3.74.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.55. This value is within the healthy range. It has increased from 0.97 (Mar 24) to 1.55, marking an increase of 0.58.
- For Retention Ratios (%), as of Mar 25, the value is 55.25. This value is within the healthy range. It has increased from 49.23 (Mar 24) to 55.25, marking an increase of 6.02.
- For Price / BV (X), as of Mar 25, the value is 6.09. This value exceeds the healthy maximum of 3. It has increased from 3.72 (Mar 24) to 6.09, marking an increase of 2.37.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.55. This value is within the healthy range. It has increased from 0.97 (Mar 24) to 1.55, marking an increase of 0.58.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.02, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Godrej Agrovet Ltd:
- Net Profit Margin: 3.72%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 19.12% (Industry Average ROCE: 15.13%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 18.04% (Industry Average ROE: 13.39%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.62
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.39
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 27.9 (Industry average Stock P/E: 22.85)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.53
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 3.72%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Animal/Shrimp Feed | Godrej One, 3rd Floor, Mumbai Maharashtra 400079 | gavlinvestors@godrejagrovet.com http://www.godrejagrovet.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Nadir B Godrej | Chairman & Non-Exe.Director |
| Mr. Balram S Yadav | Managing Director |
| Mr. Burjis Godrej | Executive Director |
| Ms. Tanya A Dubash | Non Executive Director |
| Ms. Nisaba Godrej | Non Executive Director |
| Mr. Pirojsha A Godrej | Non Executive Director |
| Mr. Kannan Sitaram | Independent Director |
| Ms. Roopa Purushothaman | Independent Director |
| Ms. Aditi Kothari Desai | Independent Director |
| Dr. Ritu Anand | Independent Director |
| Mr. Natarajan Srinivasan | Independent Director |
| Ms. Ritu Verma | Independent Director |
| Dr. Ashok Gulati | Independent Director |
FAQ
What is the intrinsic value of Godrej Agrovet Ltd?
Godrej Agrovet Ltd's intrinsic value (as of 29 October 2025) is 498.06 which is 24.54% lower the current market price of 660.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 12,703 Cr. market cap, FY2025-2026 high/low of 876/645, reserves of ₹2,189 Cr, and liabilities of 5,505 Cr.
What is the Market Cap of Godrej Agrovet Ltd?
The Market Cap of Godrej Agrovet Ltd is 12,703 Cr..
What is the current Stock Price of Godrej Agrovet Ltd as on 29 October 2025?
The current stock price of Godrej Agrovet Ltd as on 29 October 2025 is 660.
What is the High / Low of Godrej Agrovet Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Godrej Agrovet Ltd stocks is 876/645.
What is the Stock P/E of Godrej Agrovet Ltd?
The Stock P/E of Godrej Agrovet Ltd is 27.9.
What is the Book Value of Godrej Agrovet Ltd?
The Book Value of Godrej Agrovet Ltd is 124.
What is the Dividend Yield of Godrej Agrovet Ltd?
The Dividend Yield of Godrej Agrovet Ltd is 1.67 %.
What is the ROCE of Godrej Agrovet Ltd?
The ROCE of Godrej Agrovet Ltd is 16.6 %.
What is the ROE of Godrej Agrovet Ltd?
The ROE of Godrej Agrovet Ltd is 17.7 %.
What is the Face Value of Godrej Agrovet Ltd?
The Face Value of Godrej Agrovet Ltd is 10.0.